PDS Biotechnology Corp Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDS Biotechnology Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PDS Biotechnology Corp for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2018 | EDGE | Edge Therapeutics, ... | Conti Kurt G | Director | Sell | J | 0.00 | 58,476 | 0 | 0 | 58.5 K to 0 (-100.00 %) |
| Mar 22 2018 | EDGE | Edge Therapeutics, ... | Macdonald R. Loch | Chief Scientific Of ... | Sell | S | 16.41 | 2,500 | 41,025 | 570,602 | 573.1 K to 570.6 K (-0.44 %) |
| Mar 21 2018 | EDGE | Edge Therapeutics, ... | Macdonald R. Loch | Chief Scientific Of ... | Sell | S | 16.52 | 2,500 | 41,300 | 573,102 | 575.6 K to 573.1 K (-0.43 %) |
| Mar 21 2018 | EDGE | Edge Therapeutics, ... | Macdonald R. Loch | Chief Scientific Of ... | Sell | S | 16.47 | 5,000 | 82,350 | 575,602 | 580.6 K to 575.6 K (-0.86 %) |
| Mar 21 2018 | EDGE | Edge Therapeutics, ... | Macdonald R. Loch | Chief Scientific Of ... | Sell | S | 16.66 | 2,500 | 41,650 | 580,602 | 583.1 K to 580.6 K (-0.43 %) |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | MIDDLEKAUFF W BRADFORD | Senior VP, GC and S ... | Option Exercise | A | 14.98 | 65,000 | 973,700 | 65,000 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | Faleck Herbert J | Chief Medical Offic ... | Option Exercise | A | 14.98 | 90,000 | 1,348,200 | 90,000 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | BRENNAN DANIEL | Chief Operating Off ... | Option Exercise | A | 14.98 | 90,000 | 1,348,200 | 90,000 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | Saik Andrew | Chief Financial Off ... | Option Exercise | A | 14.98 | 50,000 | 749,000 | 50,000 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | Wyant Alyssa | SVP Regulatory Affa ... | Option Exercise | A | 14.98 | 50,000 | 749,000 | 50,000 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | MARCHIO ALBERT N II | Chief Accounting & ... | Option Exercise | A | 14.98 | 25,000 | 374,500 | 25,000 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | A | 14.98 | 280,000 | 4,194,400 | 280,000 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 15.08 | 2,500 | 37,700 | 70,236 | 72.7 K to 70.2 K (-3.44 %) |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 14.81 | 2,500 | 37,025 | 72,736 | 75.2 K to 72.7 K (-3.32 %) |